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SUMMARY
Here we investigate the extent to which different Aspergillus species release galactomannan (GM) in vitro. Marked variability 
was observed in GM reactivity between and within Aspergillus species, with A. terreus strains showing the highest GM indexes. The 
in vivo significance of these findings remains to be determined.
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INTRODUCTION
Galactomannan (GM) is a termostable polysaccharide that is a 
component of the cell wall of a diverse range of fungi, including those 
belonging to the genus Aspergillus1. Since GM is released during fungal 
hyphal growth, its detection in circulation or in other body fluids allows 
for an early diagnosis of invasive aspergillosis (IA)4. However, when 
interpreting a positive GM result in a patient with suspected IA, one 
might consider the variety of factors that can potentially interfere with 
the test, including antibiotic use, dietary factors and cross-reactivity with 
non-Aspergillus fungi3,9,10. Although early investigations have suggested 
that GM levels may vary among Aspergillus species7, there is still only 
very limited data to support this. Here we report that marked inter-
species and intra-species variation occurs in the Aspergilli, considering 
GM release in vitro.
MATERIALS AND METHODS
Exoantigen testing was based on the method described by SWANINK 
et al.8, in 12 well-characterized Aspergillus strains. All strains were kindly 
provided by Myconostica (National Aspergillosis Centre, UK). These 
included A. fumigatus (n = 4) strains Af294, Af10, Af71, and Af13073; 
A. flavus (n = 2), Afl5, and Afl16883; A. niger (n = 3), An9029, An1015, 
and An186; A. terreus (n = 2), At10071, and At49; and A. nidulans (n = 1), 
strain NEQAS UK. In brief, strains were subcultured to obtain pure 
young cultures in Sabouraud at 25 ºC for 48 h (A. fumigatus, A. flavus 
and A. niger) or 96 h (A. terreus and A. nidulans). One loop of each strain 
was used to prepare the inoculum in liquid Sabouraud medium, which 
was adjusted by spectrophotometry (530 nm) to 80-82% T (2x105 to 
2.5x106  FC/mL). Strains were incubated at 35 ºC for 48-96 h, centrifuged 
for five min with 2500 rpm and then filtered (Millipore 0.45 µm). Tenfold 
dilutions were applied successively, and reactivity of the sandwich ELISA 
to GM detection was determined in duplicate at the 10-6 dilution, using 
Platelia Aspergillus EIA kit (BioRad). The Platelia Aspergillus test was 
performed according to manufacturer’s instructions. In short, 100 µL of 
Platelia treatment solution (4% ethylenediaminetetraacetic acid solution) 
was added to 300 µL of the adjusted innoculum, homogenized, and 
heated to 120 °C for six min in a heat block, followed by centrifugation 
at 10,000g for 10 min. Next, 50 µL of the supernatant and 50 µL of the 
horseradish peroxidase labeled monoclonal antibody (EBA-2) were 
incubated in antibody precoated microplates for 90 min at 37 °C. The 
plates were washed five times and incubated with 200 µL of substrate 
chromogen reaction solution for 30 ± 5 min in the dark at room 
temperature. The reaction was stopped with 1.5 N sulfuric acid solution, 
and the plates were read at an optical density (OD) of 450 nm, with a 
reference filter of 620/630 nm. Positive, negative, and cut-off controls 
were incorporated in each assay. GM results were expressed as optical 
densities (OD) – samples were considered positive when the ratio between 
the OD observed for the sample and the mean cut-off OD was > 0.5. 
Strains resulting in negative GM readings were again tested in duplicate 
at the previous dilution (10-5).
RESULTS
Median GM indexes (range) at the 10-6 dilution were: A. terreus, 
3.82 (1.30 to > 6.35); A. nidulans, 1.3; A. fumigatus, 0.88 (0.17-1.50); 
A. niger, 0.28 (0.24-0.79), and A. flavus, 0.16 (0.14-0.18). Considering 
A. fumigatus as the comparator, GM reactivity for the other Aspergillus 
species was 434% for A. terreus, 148% for A. nidulans, 32% for A. niger, 
and 18% for A. flavus. At the 10-6 dilution 50% of the A. fumigatus strains 
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(Af10 and Af71) were GM negative, as well as the two A. flavus strains 
and two out of the three A. niger strains tested (An186 and An9029). 
These were all positive at 10-5 dilution, with GM indexes varying from 
0.51 to 1.02.
DISCUSSION
This study showed that marked variations occurred in GM release 
among Aspergillus species, with the highest GM indexes being observed for 
A. terreus. On the other hand, A. niger and A. flavus showed less reactivity 
in the GM ELISA test, in comparison to A. fumigatus. Previous studies 
had already suggested that in vitro GM release may vary according to 
the Aspergillus species being tested3,8. However, varied results have been 
observed among studies. For instance, two previous investigations found 
that A. niger isolates produced more GM than A. fumigatus7,8. Even though 
limited GM release by A. flavus was documented in our study as well as 
in the study by MENNINK-KERSTEN et al.7 (which was presented in 
abstract form only), SWANINK et al.8 showed that GM reactivity was 7% 
higher in A. flavus, in comparison to A. fumigatus. Common to all studies 
was the observation that A. terreus produces more GM than A. fumigatus7,8.
One explanation for the lower amount of in vitro GM release in A. 
niger and A. flavus strains, in comparison to A. fumigatus, is the fact 
that A. fumigatus clearly demonstrates a higher germination rate at 
37 °C2, a temperature that was similar to the incubation temperature 
used in our experiment (35 °C). However, considering that both A. 
terreus and A. nidulans showed higher GM release in comparison to 
A. fumigatus, although they had been submitted to a higher period of 
incubation (96 h versus 48 h), these two species grew slower than A. 
fumigatus at 37 °C2, and therefore germination rate by itself does not 
seem to explain the observed difference in GM indexes. Another potential 
explanation for such variability in GM levels is related to the quantity of 
β-D-galactofuranosidase produced by different Aspergillus strains. By 
degrading GM epitopes, the enzyme may interfere with the immunoassay 
by blocking the antigen-antibody complex formation. The demonstration 
that A. fumigatus produces 2-20% of the β-D-galactofuranosidase 
produced by A. niger6 suggests that A. fumigatus could react more avidly 
in the GM EIA test than A. niger, as found in the current study. The 
influence of the β-D-galactofuranosidase on GM levels is not completely 
clear, since similar enzyme activity has been observed for patients with IA 
caused by A. fumigatus in spite of serum GM levels5. The impact of other 
variables, such as medium pH, glucose concentration and development 
fungal stage could not be addressed in the present study since all strains 
were submitted to the same test condition.
If the results of our study are confirmed in vivo, then differences 
in serum GM levels observed among patients with IA may also be 
related to the Aspergillus species causing the infection. As a result, 
caution would be required when diagnosing IA based on the use of a 
universal cut-off for serum GM detection (i.e., 0.5). In fact, a clinical 
study involving haematological patients showed higher sensitivity of the 
Platelia Aspergillus EIA test in the diagnosis of IA when the infection 
was caused by Aspergillus species other than A. fumigatus (49% vs. 
13%, in comparison to A. fumigatus, respectively)5. One interesting 
finding of our study was the observation that variability in GM levels also 
occurred within each of the Aspergillus species evaluated. For instance, 
the magnitude of such differences was as high as ninefold, and this could 
potentially explain the difference in results obtained among studies.
In conclusion, this study showed that marked variations occurred in GM 
levels among distinct Aspergillus species, as well as among different strains 
belonging to the same species. It remains to be determined whether such 
differences could affect the determination of GM concentrations in vivo.
RESUMO
Variabilidade na detecção de galactomanana pelo Platelia 
Aspergillus EIA® de acordo com a espécie de Aspergillus
O estudo objetivou investigar a liberação in vitro de galactomanana 
(GM) em distintas espécies patogênicas de fungos do gênero Aspergillus. 
Grande variabilidade foi detectada tanto intra quanto inter espécies, sendo 
as cepas da espécie A. terreus relacionadas aos maiores índices de GM 
detectados. O significado in vivo destes achados permanece em aberto, 
porém merece investigação.
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Aspergillus strain Galactomannan optical density
A. fumigatus (Af 294) 1.50
A. fumigatus (Af 10) 0.33
A. fumigatus (Af 71) 0.17
A. fumigatus (Af 13073) 1.43
A. flavus (Afl 5) 0.18
A. flavus (Afl 16883) 0.14
A. niger (An 9029) 0.28
A. niger (An 1015) 0.79
A. niger (An 186) 0.24
A. terreus (At 10071) 1.30
A. terreus (At 49) > 6.35
A. nidulans (NEQAS UK) 1.30
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